Diverse mechanisms of PARP inhibitor resistance in ovarian cancer

被引：19
|
作者：
Wakefield, Matthew John [1 ,2 ]
Nesic, Ksenija [1 ,3 ]
Kondrashova, Olga [4 ]
Scott, Clare L. [1 ,2 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
[4] QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2019年 / 1872卷 / 02期
基金：
英国医学研究理事会;
关键词：
REPLICATION FORK REVERSAL; CELL-FREE DNA; HOMOLOGOUS RECOMBINATION; MRE11-DEPENDENT DEGRADATION; GERMLINE MUTATIONS; EXCISION-REPAIR; MUTANT-CELLS; NASCENT DNA; BRCA2; STABILITY;
D O I：
10.1016/j.bbcan.2019.08.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Mechanisms of PARP inhibitor resistance in ovarian cancer
    Kubalanza, Kari
    Konecny, Gottfried E.
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 36 - 41
  • [2] Overcoming PARP inhibitor resistance in ovarian cancer
    Pina, Pamela Soberanis
    Lheureux, Stephanie
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 364 - 376
  • [3] PARP Inhibitor Resistance and Acquired Vulnerability in Ovarian Cancer
    D'Andrea, Alan
    [J]. ONCOLOGIST, 2017, 22 : S1 - S1
  • [4] Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
    McMullen, Michelle
    Karakasis, Katherine
    Madariaga, Ainhoa
    Oza, Amit M.
    [J]. CANCERS, 2020, 12 (06) : 1 - 18
  • [5] Combining PARP inhibitor with TACC3 inhibition overcomes PARP inhibitor resistance in ovarian cancer
    Wu, Yu
    Wang, Qilong
    Deng, Chaolin
    Li, Mo
    Xiao, Yinan
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [6] PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
    Jiang, Xuan
    Li, Xiaoying
    Li, Weihua
    Bai, Huimin
    Zhang, Zhenyu
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (04) : 2303 - 2313
  • [7] Combining PARP inhibitor with cMET Inhibition overcomes PARP inhibitor resistance in epithelial ovarian cancer.
    Kim, Min-Je
    Lee, Shin-Wha
    Lee, Young-Jae
    Park, Su-Bin
    Kang, Dong-Woo
    Kim, Yong-Man
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [8] PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes
    Yu, Tony
    Lok, Benjamin H.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2024,
  • [9] Mechanisms of PARP inhibitor sensitivity and resistance
    D'Andrea, Alan D.
    [J]. DNA REPAIR, 2018, 71 : 172 - 176
  • [10] Novel mechanisms of PARP inhibitor resistance
    D'Andrea, Alan D.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345